These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 22540538)
21. Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys. Nishimuta H; Sato K; Mizuki Y; Yabuki M; Komuro S Drug Metab Dispos; 2010 Nov; 38(11):1967-75. PubMed ID: 20702772 [TBL] [Abstract][Full Text] [Related]
22. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases. Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670 [TBL] [Abstract][Full Text] [Related]
23. Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences. Wen Z; Martin DE; Bullock P; Lee KH; Smith PC Drug Metab Dispos; 2007 Mar; 35(3):440-8. PubMed ID: 17151190 [TBL] [Abstract][Full Text] [Related]
24. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises. Miners JO; Knights KM; Houston JB; Mackenzie PI Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060 [TBL] [Abstract][Full Text] [Related]
25. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms. Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045 [TBL] [Abstract][Full Text] [Related]
26. Species differences in UDP-glucuronosyltransferase activities in mice and rats. Shiratani H; Katoh M; Nakajima M; Yokoi T Drug Metab Dispos; 2008 Sep; 36(9):1745-52. PubMed ID: 18505787 [TBL] [Abstract][Full Text] [Related]
27. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine. Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623 [TBL] [Abstract][Full Text] [Related]
28. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases. Hoehle SI; Pfeiffer E; Metzler M Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876 [TBL] [Abstract][Full Text] [Related]
29. Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid. Miles KK; Kessler FK; Smith PC; Ritter JK Drug Metab Dispos; 2006 Sep; 34(9):1632-9. PubMed ID: 16790558 [TBL] [Abstract][Full Text] [Related]
30. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay. Di Marco A; D'Antoni M; Attaccalite S; Carotenuto P; Laufer R Drug Metab Dispos; 2005 Jun; 33(6):812-9. PubMed ID: 15788539 [TBL] [Abstract][Full Text] [Related]
31. Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver. Yasuda K; Ikushiro S; Kamakura M; Munetsuna E; Ohta M; Sakaki T Drug Metab Dispos; 2011 Sep; 39(9):1538-45. PubMed ID: 21622626 [TBL] [Abstract][Full Text] [Related]
32. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Hanioka N; Naito T; Narimatsu S Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428 [TBL] [Abstract][Full Text] [Related]
33. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Kaivosaari S; Toivonen P; Aitio O; Sipilä J; Koskinen M; Salonen JS; Finel M Drug Metab Dispos; 2008 Aug; 36(8):1529-37. PubMed ID: 18474681 [TBL] [Abstract][Full Text] [Related]
34. Resveratrol (trans-resveratrol, 3,5,4'-trihydroxy-trans-stilbene) glucuronidation exhibits atypical enzyme kinetics in various protein sources. Iwuchukwu OF; Nagar S Drug Metab Dispos; 2008 Feb; 36(2):322-30. PubMed ID: 17991766 [TBL] [Abstract][Full Text] [Related]
36. Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential. Wang Q; Hao H; Zhu X; Yu G; Lai L; Liu Y; Wang Y; Jiang S; Wang G Drug Metab Dispos; 2010 Jul; 38(7):1132-40. PubMed ID: 20382756 [TBL] [Abstract][Full Text] [Related]
37. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics. Wen Z; Tallman MN; Ali SY; Smith PC Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191 [TBL] [Abstract][Full Text] [Related]
38. Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches. Stevens JC; Fayer JL; Cassidy KC Drug Metab Dispos; 2001 Mar; 29(3):289-95. PubMed ID: 11181497 [TBL] [Abstract][Full Text] [Related]
39. S-equol glucuronidation in liver and intestinal microsomes of humans, monkeys, dogs, rats, and mice. Isobe T; Ohkawara S; Ochi S; Tanaka-Kagawa T; Hanioka N Food Chem Toxicol; 2019 Sep; 131():110542. PubMed ID: 31163218 [TBL] [Abstract][Full Text] [Related]
40. Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells. Zhang H; Tolonen A; Rousu T; Hirvonen J; Finel M Drug Metab Dispos; 2011 Mar; 39(3):456-64. PubMed ID: 21098645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]